Study guide

16.2 Labor Analgesia & Anesthesia for Cesarean Delivery

NBCRNA CRNA Certified Registered Nurse Anesthetist NCE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology

1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders

2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems

2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms

3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology

4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics

4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics

5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies

5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout

6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators

6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging

7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation

7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways

8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety

8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety

9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation

9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication

10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring

10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies

11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms

11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)

12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA

12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm

13 Chapter 13: Regional Anesthesia: Neuraxial Blocks

13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma

14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance

14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols

15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice

15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives

16 Chapter 16: Obstetric & Gynecologic Anesthesia

16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient

17 Chapter 17: Pediatric Anesthesia

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm

18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia

18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia

19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia

20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements

22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology

22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices

23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures

23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases

24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control

24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure

25 Chapter 25: Neurosurgical Subspecialty Procedures

25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy

26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia

26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery

27 Chapter 27: Orthopedic & Extremity Anesthesia

27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block

28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy

28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia

29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient

16.2 Labor Analgesia & Anesthesia for Cesarean Delivery

Key Takeaways Explain This Topic AI

First-stage labor pain (cervical dilation and lower uterine segment stretch) is visceral, transmitted via sympathetic afferents entering the spinal cord at T10-L1; second-stage labor pain (perineal and pelvic floor distension) is somatic, transmitted via the pudendal nerve at S2-S4.

Programmed Intermittent Epidural Boluses (PIEB) combined with Patient-Controlled Epidural Analgesia (PCEA) using low-concentration bupivacaine (0.0625-0.1%) and fentanyl (2 mcg/mL) provides superior sensory spread with reduced motor block compared to continuous infusions.

Surgical anesthesia for Cesarean delivery requires a solid bilateral sensory dermatomal block to T4 (nipple line) to eliminate visceral pain during peritoneal exteriorization and uterine manipulation.

Emergent conversion of a labor epidural to surgical anesthesia is best achieved with 15-20 mL of 2% lidocaine with 1:200,000 epinephrine plus 8.4% sodium bicarbonate (1 mL per 10 mL lidocaine) or 3% 2-chloroprocaine.

Postpartum uterotonic management follows a strict pharmacologic rule: Oxytocin is first-line (administered as a slow IV infusion, never rapid bolus); Methylergonovine (Methergine 0.2 mg IM) is strictly contraindicated in hypertension/preeclampsia; Carboprost (Hemabate 0.25 mg IM) is strictly contraindicated in asthma.

Last updated: August 2026

16.2 Labor Analgesia & Anesthesia for Cesarean Delivery

Providing safe, effective analgesia and anesthesia for labor and operative delivery is a cornerstone of nurse anesthesia practice. Understanding the distinct sensory neuroanatomy of labor, the pharmacodynamics of neuraxial local anesthetic-opioid combinations, and the pharmacology of uterotonics is critical for optimizing maternal-neonatal outcomes.

1. Neuroanatomy of Labor Pain Pathways

Labor pain progresses along distinct anatomical pathways as delivery advances from the first to the second stage. +---------------------------------------------------------------------------------------------------------+

  • | LABOR PAIN NEUROANATOMY & INNERVATION |
  • +------------------+------------------------------+---------------------------+---------------------------+
  • | Labor Stage | Anatomic Origin of Stimulus | Nerve Fiber Type | Spinal Cord Entry Level |
  • +------------------+------------------------------+---------------------------+---------------------------+
  • | **First Stage** | • Cervical dilation | • Visceral Afferent | **T10, T11, T12, and L1** |
  • | (Latent & Active)| • Lower uterine segment | C-fibers (travel with | (Referred to lower back, |
  • | | stretching & ischemia | sympathetic nerves) | abdomen, and flanks) |
  • +------------------+------------------------------+---------------------------+---------------------------+
  • | **Second Stage** | • Pelvic floor distension | • Somatic Afferent | **S2, S3, and S4** |
  • | (Pushing/Descent)| • Vagina, vulva, and | A-delta and C-fibers | (Via **Pudendal Nerve**; |
  • | | perineal stretching | | perineum and rectum) |
  • +------------------+------------------------------+---------------------------+---------------------------+
  • | **Third Stage** | • Placental separation | • Combined Visceral & | **T10 – L1 and S2 – S4** |
  • | (Delivery of Pl.)| • Uterine involution | Somatic Afferents | |

+------------------+------------------------------+---------------------------+---------------------------+ [LABOR PAIN PATHWAYS & DERMATOMAL TARGETS]

  • [STAGE 1 LABOR PAIN: T10 - L1] [STAGE 2 LABOR PAIN: S2 - S4]
  • (Uterine Contraction & Cervix) (Pelvic Floor & Perineum)
  • | |
  • v v
  • Paracervical & Hypogastric Plexus Pudendal Nerve
  • | |
  • v v
  • Lumbar Sympathetic Chain Sacral Nerve Roots
  • | |
  • v v
  • **Dorsal Horn Entry: T10 - L1** **Dorsal Horn Entry: S2 - S4**
  • 2. Neuraxial Labor Analgesia Techniques
  • 1. Lumbar Epidural Analgesia (LEA)

Anatomy & Insertion: Inserted at the L 3 − L 4 L3 - L4 L 3 − L 4 or L 4 − L 5 L4 - L5 L 4 − L 5 interspace with the patient in the seated or lateral decubitus position. Loss of Resistance to Saline (LORS) with a small air bubble is preferred over pure Loss of Resistance to Air (LORA), as air injection increases the incidence of patchy/incomplete blocks, accidental venous air embolism, and pneumocephalus-induced post-dural puncture headache.

Depth: Skin-to-epidural space distance is typically 4 − 6 cm 4 - 6 \text{ cm} 4 − 6 cm in average-weight parturients (up to 8 − 10 cm 8 - 10 \text{ cm} 8 − 10 cm in morbid obesity). The catheter is threaded 3 − 5 cm 3 - 5 \text{ cm} 3 − 5 cm into the epidural space (threading < 3 cm <3 \text{ cm} < 3 cm risks dislodgement; > 5 cm >5 \text{ cm} > 5 cm increases unilateral block and vein cannulation).

The Epidural Test Dose: 3 mL 3 \text{ mL} 3 mL of 1.5 % 1.5\% 1.5% Lidocaine with 1 : 200 , 000 1:200,000 1 : 200 , 000 Epinephrine ( 45 mg 45 \text{ mg} 45 mg lidocaine + 15 mcg + 15 \text{ mcg} + 15 mcg epinephrine):

Intravascular Injection Sign: Heart rate increase of ≥ 20 bpm \ge 20 \text{ bpm} ≥ 20 bpm or systolic BP increase of ≥ 15 mmHg \ge 15 \text{ mmHg} ≥ 15 mmHg within 30 − 60 seconds 30 - 60 \text{ seconds} 30 − 60 seconds (or metallic taste, perioral numbness, tinnitus).

Subarachnoid Injection Sign: Development of dense motor block and sensory block within 2 − 3 minutes 2 - 3 \text{ minutes} 2 − 3 minutes .

Maintenance Regimens: Modern labor analgesia utilizes ultra-low concentration local anesthetics combined with lipophilic opioids:

Solution: Bupivacaine 0.0625 % − 0.1 % 0.0625\% - 0.1\% 0.0625% − 0.1% or Ropivacaine 0.1 % − 0.2 % 0.1\% - 0.2\% 0.1% − 0.2% with Fentanyl 2 mcg/mL 2 \text{ mcg/mL} 2 mcg/mL (or Sufentanil 0.3 mcg/mL 0.3 \text{ mcg/mL} 0.3 mcg/mL ).

Delivery Mode: Programmed Intermittent Epidural Bolus (PIEB) with Patient-Controlled Epidural Analgesia (PCEA) is superior to continuous background infusions. Automated boluses (e.g., 8 − 10 mL 8 - 10 \text{ mL} 8 − 10 mL every 40 − 45 minutes 40 - 45 \text{ minutes} 40 − 45 minutes ) generate higher injection pressure, creating uniform spherical spread throughout the epidural space, improving sacral coverage, lowering total drug consumption, and reducing instrumented vaginal deliveries.

2. Combined Spinal-Epidural (CSE) & Dural Puncture Epidural (DPE)

Combined Spinal-Epidural (CSE): Utilizes a needle-through-needle technique. An initial intrathecal dose of Bupivacaine 1.25 − 2.5 mg 1.25 - 2.5 \text{ mg} 1.25 − 2.5 mg + Fentanyl 15 − 25 mcg 15 - 25 \text{ mcg} 15 − 25 mcg (or Sufentanil 2.5 − 5 mcg 2.5 - 5 \text{ mcg} 2.5 − 5 mcg ) is injected into the CSF, providing near-instantaneous, dense analgesia within 2 − 3 minutes 2 - 3 \text{ minutes} 2 − 3 minutes . The epidural catheter is then threaded for ongoing maintenance.

Clinical Caveat: Rapid pain relief from CSE causes a sudden drop in maternal catecholamines, which can trigger transient uterine hypertonus and fetal bradycardia in 5 − 10 % 5 - 10\% 5 − 10% of cases.

Dural Puncture Epidural (DPE): A 25 G 25G 25 G or 27 G 27G 27 G Whitacre spinal needle is used to puncture the dura without injecting intrathecal medications; the needle is withdrawn and the epidural catheter is placed. The dural micro-hole allows transmeningeal flux of epidurally administered local anesthetics into the CSF, enhancing sacral analgesia and speeding onset without the fetal bradycardia risks of CSE.

3. Anesthesia for Cesarean Delivery +---------------------------------------------------------------------------------------------------------+

  • | CESAREAN DELIVERY ANESTHETIC MODALITIES |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | Modality | Target Sensory | Primary Medication | Key Clinical Pearls |
  • | | Dermatome Level | Regimen | & Pitfalls |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Spinal Anesthesia**| **T4 (Nipple)** | • 0.75% Hyperbaric | • Gold standard for elective C-section |
  • | (Single-Shot) | | Bupivacaine: | • Co-load crystalloid/colloid at block |
  • | | | **10.5 - 13.5 mg**| • Prophylactic Phenylephrine infusion |
  • | | | • Fentanyl: | (25-50 mcg/min) prevents hypotension |
  • | | | **10 - 15 mcg** | • Duramorph provides 18-24h postop pain |
  • | | | • Duramorph: | control; monitor for delayed resp dep |
  • | | | **100 - 150 mcg** | |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Epidural | **T4 (Nipple)** | • 2% Lidocaine with | • Add 8.4% Sodium Bicarbonate (1 mL per |
  • | Extension** | | Epinephrine | 10 mL lidocaine) to hasten onset |
  • | (Converting labor | | 1:200k (15-20 mL) | • 3% 2-Chloroprocaine (15-20 mL) provides|
  • | epidural to C/S) | | OR | fastest onset (3-5 min) via plasma |
  • | | | • 3% 2-Chloroprocaine| pseudocholinesterase metabolism |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **General | Intubated General | • Propofol 2 mg/kg | • Reserved for emergent fetal distress, |
  • | Anesthesia (RSI)**| Endotracheal | (or Ketamine 1 mg)| severe hemorrhage, or failed regional |
  • | | Anesthesia | • Succinylcholine | • High aspiration & difficult airway |
  • | | | 1.0 - 1.5 mg/kg | risks; cuffed 6.0-6.5 ETT; extubate |
  • | | | • 0.5 - 0.75 MAC gas| only when 100% fully awake |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • Why T4 Sensory Dermatome Level is Mandatory

A sensory block to T4 (nipple level) is mandatory for Cesarean delivery. While the uterine incision is located at T 10 − L 1 T10 - L1 T 10 − L 1 , the surgical procedure involves manipulation of the peritoneum, traction on the bladder flap, exteriorization of the uterus, and irrigation of the upper abdominal gutters. These peritoneal structures are innervated by higher thoracic and vagal afferents. A block below T4 results in severe visceral pain, dyspnea, nausea, and diaphoresis during exteriorization.

Rapid Epidural Extension Protocol

When an in-situ labor epidural catheter must be urgently converted for Cesarean delivery:

Alkalinized Lidocaine with Epinephrine: Administer 15 − 20 mL 15 - 20 \text{ mL} 15 − 20 mL of 2 % 2\% 2% Lidocaine with 1 : 200 , 000 1:200,000 1 : 200 , 000 Epinephrine mixed with 8.4 % 8.4\% 8.4% Sodium Bicarbonate ( 1 mL 1 \text{ mL} 1 mL per 10 mL 10 \text{ mL} 10 mL lidocaine) . Bicarbonate raises the solution pH, dramatically increasing the un-ionized lipid-soluble fraction of lidocaine, accelerating onset from 15 − 20 minutes 15 - 20 \text{ minutes} 15 − 20 minutes down to 5 − 8 minutes 5 - 8 \text{ minutes} 5 − 8 minutes .

3% 2-Chloroprocaine: Administer 15 − 20 mL 15 - 20 \text{ mL} 15 − 20 mL of 3 % 3\% 3% 2-Chloroprocaine . This ester local anesthetic provides the fastest known onset ( 3 − 5 minutes 3 - 5 \text{ minutes} 3 − 5 minutes ) and is metabolized immediately by plasma pseudocholinesterase. Note: Chloroprocaine may reduce the efficacy of subsequent epidural opioids (mu-antagonist effect) and subsequent bupivacaine.

General Anesthesia for Cesarean Section: RSI Protocol

General anesthesia is indicated for acute non-reassuring fetal status (e.g., sustained fetal bradycardia < 60 bpm <60 \text{ bpm} < 60 bpm , severe cord prolapse), massive maternal hemorrhage/shock, coagulopathy (platelets < 50 , 000 / mm 3 <50,000/\text{mm}^3 < 50 , 000/ mm 3 ), or failed neuraxial block.

Preparation: Administer non-particulate antacid ( 0.3 M Sodium Citrate / Bicitra 30 mL 30 \text{ mL} 30 mL PO ) within 30 minutes 30 \text{ minutes} 30 minutes of induction. Position patient with 15 ∘ 15^\circ 1 5 ∘ LUD and ramped head-up alignment.

Surgical Timing: The surgical team must prep and drape the abdomen, confirm all instrumentation is ready, and stand with scalpel in hand before induction to minimize induction-to-delivery (I-D) time and fetal drug exposure.

Induction & Airway: Rapid Sequence Induction with cricoid pressure ( Sellick's maneuver ). Administer Propofol 2 − 2.5 mg/kg 2 - 2.5 \text{ mg/kg} 2 − 2.5 mg/kg IV (or Ketamine 1 − 1.5 mg/kg 1 - 1.5 \text{ mg/kg} 1 − 1.5 mg/kg IV if hemodynamically unstable) followed immediately by Succinylcholine 1.0 − 1.5 mg/kg 1.0 - 1.5 \text{ mg/kg} 1.0 − 1.5 mg/kg IV (or Rocuronium 1.2 mg/kg 1.2 \text{ mg/kg} 1.2 mg/kg IV with Sugammadex on standby). Secure airway with a 6.0 − 6.5 mm 6.0 - 6.5 \text{ mm} 6.0 − 6.5 mm cuffed ETT .

Maintenance: Administer 50 % O 2 50\% \text{ O}_2 50% O 2 ​ in air/nitrous oxide with 0.5 − 0.75 MAC 0.5 - 0.75 \text{ MAC} 0.5 − 0.75 MAC volatile anesthetic prior to delivery. This prevents maternal awareness while avoiding volatile-induced uterine relaxation and atony.

Post-Delivery: Immediately upon umbilical cord clamping, reduce volatile anesthetic to ≤ 0.5 MAC \le 0.5 \text{ MAC} ≤ 0.5 MAC , administer IV opioids (fentanyl, hydromorphone), midazolam, and initiate high-dose Uterotonic infusions to contract the uterus.

Extubation: Extubate only when the patient is 100% wide awake, following commands, with fully reversed neuromuscular blockade and intact protective airway reflexes in the sitting or semi-lateral position.

4. Post-Delivery Uterotonics & Management of Uterine Atony

Uterine atony is responsible for up to 80 % 80\% 80% of all postpartum hemorrhage (PPH) cases. Once the placenta is delivered, myometrial contraction mechanically compresses the interlacing uterine blood vessels ("physiologic ligatures"). The CRNA must know the precise dosing, mechanics, and critical contraindications of all second-line uterotonics. +---------------------------------------------------------------------------------------------------------+

  • | POSTPARTUM UTEROTONIC PHARMACOPEIA |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | Drug & Class | Standard Dosing | Mechanism of Action | Critical Contraindications & Warnings |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Oxytocin** | • 10 - 40 units | • Gq-coupled | • **NEVER GIVE RAPID IV BOLUS!** |
  • | *(Pitocin)* | in 1000 mL IV | oxytocin receptor | • Rapid bolus causes profound vascular |
  • | *First-Line Agent* | infusion | activation | collapse, hypotension, reflex tachy, |
  • | | • "Rule of 3s": | • Opens L-type Ca2+ | coronary vasospasm, myocardial isch. |
  • | | 3 units slow IV | channels | • Large doses cause antidiuretic water |
  • | | over ≥30 sec | | intoxication / severe hyponatremia |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Methylergonovine**| • **0.2 mg IM** | • Ergot alkaloid; | • **ABSOLUTELY CONTRAINDICATED IN:** |
  • | *(Methergine)* | (or intramyomet)| stimulates alpha- | **Hypertension, Preeclampsia, CAD,** |
  • | *Second-Line Agent* | • **NEVER IV!** | adrenergic and | **Raynaud's, Peripheral Vasc Disease**|
  • | | (Repeat q2-4h) | 5-HT receptors | • Triggers catastrophic malignant HTN, |
  • | | | • Sustained tetany | intracerebral hemorrhage, stroke |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Carboprost | • **0.25 mg IM** | • Prostaglandin F2α | • **ABSOLUTELY CONTRAINDICATED IN:** |
  • | Tromethamine** | (250 mcg IM or | analog | **Asthma / Reactive Airway Disease,** |
  • | *(Hemabate)* | intramyometrial)| • Direct myometrial | **Severe Pulmonary Hypertension** |
  • | *Second-Line Agent* | • Repeat q15-90min| calcium influx | • Triggers intense bronchoconstriction, |
  • | | (Max: 8 doses) | | pulmonary HTN, severe V/Q mismatch |
  • | | | | • Side effects: Profuse watery diarrhea |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Misoprostol** | • 600 - 1000 mcg | • Synthetic PGE1 | • **Safe in Asthma and Hypertension!** |
  • | *(Cytotec)* | sublingual, PR, | analog | • Side effects: High fevers/hyperpyrexia|
  • | *Adjunctive Agent* | or buccal | • Promotes uterine | (up to 40°C), transient shivering, |
  • | | | contractility | gastrointestinal cramping |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Tranexamic Acid** | • **1 g IV over** | • Synthetic lysine | • Administer within 3 hours of bleeding |
  • | *(TXA / WOMAN Tr.)* | **10 minutes** | analog; inhibits | • Repeat 1 g IV after 30 min if ongoing |
  • | | • Repeat in 30 min| plasminogen | • Rapid infusion can cause hypotension |

+---------------------+-------------------+---------------------+-----------------------------------------+ [SECOND-LINE UTEROTONIC CONTRAINDICATION MATRIX]

  • [PATIENT HAS HYPERTENSION / PREECLAMPSIA] [PATIENT HAS ASTHMA / REACTIVE AIRWAY]
  • | |
  • v v
  • **NO METHERGINE!** (0.2 mg IM) **NO HEMABATE!** (0.25 mg IM)
  • Causes Severe Vasospasm & Causes Severe Bronchospasm &
  • Catastrophic Hypertensive Crisis Pulmonary Vasoconstriction
  • | |
  • v v
  • USE HEMABATE or MISOPROSTOL USE METHERGINE or MISOPROSTOL

Loading diagram... Labor Pain Pathways & Uterotonic Decision Algorithm